Advertisement
Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

Page Physicians with Instant Message on iPad

March 20, 2011 7:36 pm | by Bio-Medicine.Org | News | Comments

DETROIT, March 20, 2011 /- Webahn, Inc. today announced that Capzule EMR, its electronic medical records iOS App for physicians, now includes instant messaging capability. Capzule (capzule.com) is an online electronic medical records platform offered to small practices as a software...

New imaging technique provides rapid, high-definition chemistry

March 20, 2011 11:33 am | by EurekAlert | News | Comments

(University of Wisconsin - Milwaukee) With intensity a million times brighter than sunlight, a new synchrotron-based imaging technique offers high-resolution pictures of the molecular composition of tissues with unprecedented speed and quality. The new technique employs multiple beams of...

New Model Provides Insights Into Intravenous and Subcutaneous Immunoglobulin Pharmacokinetics in Patients With Primary Immunodeficiencies

March 19, 2011 9:34 am | by Bio-Medicine.Org | News | Comments

KING OF PRUSSIA, Pa., March 19, 2011 /- CSL Behring today announced the development of an innovative pharmacokinetic (PK) model that allows the absorption, distribution, metabolism, and elimination of subcutaneous (SC) immunoglobulin G (IgG) following administration to be simulated with a...

Advertisement

Covidien Announces FDA Advisory Committee Unanimously Recommends Approval for Pipeline(TM) Embolization Device

March 18, 2011 7:35 pm | by Covidien | News | Comments

MANSFIELD, Mass., Mar 18, 2011 (BUSINESS WIRE) --Covidien (NYSE:COV), a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration (FDA) Neurological Devices Advisory Panel voted to recommend approval for Pipeline(TM) Embolization Device,...

FDA Panel Struggles to Agree on Effectiveness of Tumor Device

March 18, 2011 2:34 pm | by U.S. Food & Drug Administration | News | Comments

An FDA advisory panel reached deadlock over the effectiveness of a novel device that blasts glioblastoma multiforme (GBM) brain tumors with an electrical field, with the panel chair breaking the tie in favor of the device.

BD Completes Acquisition of Accuri Cytometers, Inc.

March 18, 2011 12:37 pm | by Bio-Medicine.Org | News | Comments

FRANKLIN LAKES, N.J., March 18, 2011 /- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global technology company, today announced the completion of its acquisition of Accuri Cytometers, Inc., an Ann Arbor, Michigan-based company that develops and manufactures personal flow...

BridgePoint Medical Names Industry Veteran as Chief Executive Officer

March 18, 2011 12:35 pm | by Bio-Medicine.Org | News | Comments

MINNEAPOLIS, March 18, 2011 /- BridgePoint Medical, Inc., a Minnesota based medical device company, has announced that Denis Harrington has joined the company as President and Chief Executive Officer.  A seasoned medical device executive with nearly two decades of experience in the...

Midland Family Undergoes Bariatric Surgery at Hurley Medical Center--Loses 445 Pounds & Countingâ??Tells their Life-Saving Story to Media on March 18, 2011

March 18, 2011 12:35 pm | by Bio-Medicine.Org | News | Comments

FLINT, Mich., March 18, 2011 /PRNewswire-USNewswire/ -- The Aeschliman family of Midland, Michigan have a new lease on life. Nancy Aeschliman Grau and her three children—Katie, Chris, and Mike ALL underwent Roux-en-Y bariatric surgery at Hurley Medical Center—the first...

Advertisement

Bi-Partisan Legislation Introduced Would Repeal Controversial Medicare 'Competitive Bidding' Requirements for Home Medical Equipment

March 18, 2011 12:34 pm | by Bio-Medicine.Org | News | Comments

HARRISBURG, Pa., March 18, 2011 /- Pennsylvania Association of Medical Suppliers (PAMS) today applauded legislation introduced by Congressmen Glenn "GT" Thompson (R-Centre) and Jason Altmire, (D-Allegheny) that would repeal Medicare's controversial competitive bidding program for home...

Turbulent Times Ahead for Independent Imaging Facilities

March 18, 2011 7:35 am | by Diagnostic Imaging | News | Comments

The uncertainty of today's healthcare environment is just another hurdle in the daily operation of an imaging facility. How this and other challenges are handled will certainly determine the viability of your business.

For Radiology Assistants: To Bill or Not to Bill?

March 18, 2011 7:35 am | by Diagnostic Imaging | News | Comments

Radiologist assistants (RAs) and radiology practitioner assistants (RPAs) may be highly educated and experienced, but CMS won't pay for their services in all settings. Reimbursement depends on the setting (office, hospital inpatient or outpatient, and independent diagnostic testing...

ViroPharma Announces Positive CHMP Opinion for Cinryze® (C1 Inhibitor Human) in European Union

March 18, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

EXTON, Pa., March 18, 2011 /- ViroPharma Incorporated (Nasdaq: VPHM ) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion at its plenary meeting in March 2011 recommending approval of a...

CooperVision Introduces New Corporate Brand Identity

March 18, 2011 5:36 am | by Bio-Medicine.Org | News | Comments

ROCHESTER, N.Y., March 18, 2011 /- Leading contact lens manufacturer, CooperVision today unveiled its new brand positioning and visual identity that better reflects the organization's values. (Logo: http://photos.prnewswire.com/prnh/20110318/NY67257LOGO) "CooperVision had a record year in...

Advertisement

'2011 China-Africa Brightness Action' Launched in Beijing

March 18, 2011 5:36 am | by Bio-Medicine.Org | News | Comments

BEIJING, March 18, 2011 /PRNewswire-Asia/ -- The launching ceremony for the "2011 China-Africa Brightness Action" was held at the Beijing HNA Marriott Hotel on March 17th. Co-organized by the National Committee of Blindness Prevention (NCBP), China Association for Promoting Democracy, the...

China-Biotics Wins First US Customer

March 18, 2011 3:39 am | by Bio-Medicine.Org | News | Comments

SHANGHAI, March 18, 2011 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. (Nasdaq: CHBT ) ("China-Biotics" or "the Company"), the leading developer, manufacturer and distributor of probiotics products in China, today announced that the Company has entered into an agreement with a US...

NIH Director Dr. Francis Collins to Present Keynote Address at Partnering for Global Health Forum 2011

March 18, 2011 3:35 am | by Biotechnology Industry Organization | News | Comments

WASHINGTON, D.C. (Wednesday, March 16, 2011) - The Biotechnology Industry Organization (BIO) and BIO Ventures for Global Health (BVGH) announced today that Francis Collins, MD, PhD, Director of the National Institutes of Health, will provide the keynote address at the Partnering for...

A Look at 115-Year-Old X-Ray Equipment

March 18, 2011 3:35 am | by Diagnostic Imaging | News | Comments

X-ray equipment has become far more sophisticated in the last 115 years - and uses far lower radiation doses and exposure times, researchers found recently after testing a first-generation system from 1896.

Radiation Safety Q & A: Can Decision Support Systems Help?

March 18, 2011 3:35 am | by Diagnostic Imaging | News | Comments

Stephen Herman, MD, an associate professor of radiology at University Health Network in Toronto, Ontario, Canada, and CEO of MedCurrent, discusses how radiology decision support systems can help reduce radiation exposure, and what it will take for the tools to catch on.

Concord Medical to Report Fourth Quarter and Fiscal Year 2010 Financial Results on Monday, March 28, 2011

March 18, 2011 3:34 am | by Bio-Medicine.Org | News | Comments

BEIJING, March 18, 2011 /PRNewswire-Asia-FirstCall/ -- Concord Medical Services Holdings Limited ("Concord Medical") (NYSE: CCM ), operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that it will report its unaudited financial results...

Quest Diagnostics to Acquire Celera, Strengthening Position as World's Leading Innovator in Molecular Diagnostics and Development

March 18, 2011 3:34 am | by Bio-Medicine.Org | News | Comments

MADISON, N.J. and ALAMEDA, Calif., March 18, 2011 /- Quest Diagnostics Incorporated (NYSE: DGX ), the world's leading provider of diagnostic testing, information and services, and Celera Corporation (Nasdaq: CRA ), one of the world's pioneers in genetic diagnostics discovery and...

Study of Patients on Chronic Opioid Therapy finds Likely Non-adherent Patients Have Increased Healthcare Costs, More Hospital Days

March 17, 2011 1:34 pm | by Bio-Medicine.Org | News | Comments

BALTIMORE, March 17, 2011 /- Patients undergoing opioid therapy for chronic pain who may not be following their prescription regimen have significantly higher overall healthcare costs, Ameritox Ltd. announced recently. The study was published in The American Journal of Managed Care ....

New targeted drug helps smokers stub it out

March 17, 2011 1:32 pm | by EurekAlert | News | Comments

(Academy of Finland) Researchers working in a research project within the Academy of Finland's Research Program on Substance Use and Addictions have been developing a targeted drug that could aid in smoking reduction therapy.

Pharmaceutics International Inc. (Pii) Announces Appointment of Rampurna Prasad Gullapalli, Ph.D. as Vice President of Drug Delivery Technologies

March 17, 2011 11:37 am | by Bio-Medicine.Org | News | Comments

HUNT VALLEY, Md.,. March 17, 2011 /- Pharmaceutics International Inc. (Pii), a leading contract development and manufacturing organization, today announced the appointment of Rampurna Prasad Gullapalli as vice president of Drug Delivery Technologies.  Dr. Gullapalli is responsible...

Research: Prostate cancer patients opt for more expensive treatment

March 17, 2011 11:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Men diagnosed with prostate cancer have been rapidly adopting new, more expensive treatment options, even without proof of their cost-effectiveness, according to research by the Dana-Farber/Brigham and Women's Hospital Cancer Center.

Research: Prostrate cancer patients opt for more expensive treatment

March 17, 2011 9:32 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Men diagnosed with prostate cancer have been rapidly adopting new, more expensive treatment options, even without proof of their cost-effectiveness, according to research by the Dana-Farber/Brigham and Women's Hospital Cancer Center.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading